All News about Virios Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17324.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220919005764/en/1096317/4/Virios_Logo_Blue.jpg)
Virios Therapeutics, Inc. Announces Proposed Public Offering
September 19, 2022
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/09/19/image34.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/19/image36.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/19/aapharma_7.png?width=1200&height=800&fit=crop)
Virios Therapeutics Shares Tank After Failing Fibromyalgia Study
September 19, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8354.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_6419.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17282.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17267.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Monday
September 19, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/19/image24.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_17270.jpeg)
![](https://investorplace.com/wp-content/uploads/2021/08/doctor_medicine_dna_1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/19/image23.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17233.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220919005288/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/15/bz-pharma_4.jpg?width=1200&height=800&fit=crop)
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 15, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/17/image11.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/15/bz-pharma.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220815005047/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20220811005052/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20220810005722/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://www.acnnewswire.com/topimg/Thumb_ViriosTherapeutics2022809.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://mms.businesswire.com/media/20220804005097/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_12623.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220601005293/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20220512005072/en/1096317/4/Virios_Logo_Blue.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.